Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.2150 (-8.67%) ($5.1600 - $5.2150) on Wed. Jun. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.72% (three month average) | RSI | 76 | Latest Price | $5.2150(-8.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 13.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XLC(44%) SKYY(42%) XLU(40%) SPLV(30%) XLP(21%) | Factors Impacting CAPR price | CAPR will decline at least -2.36% in a week (0% probabilities). IFRA(-18%) IYT(-9%) JETS(4%) IWD(5%) IWN(24%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.36% (StdDev 4.72%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.36(-2.71%) | 10 Day Moving Average | $4.94(5.57%) | 20 Day Moving Average | $4.49(16.15%) | To recent high | -8.7% | To recent low | 3.7% | Market Cap | $103m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |